From the Cosmetic Dermatology Archives

The Road Less Injected

The plethora of new injectable products has created new opportunities for physicians to treat areas previously thought to be unresponsive to soft-tissue augmentation. Use of these products has dramatically increased the demand for nonsurgical facial rejuvenation, and with this increase, there is a concomitant desire to treat areas not traditionally injected. These areas may be addressed with a high degree of patient satisfaction.


 

Recommended Reading

PDT May Have a Future in Chemoprevention
MDedge Dermatology
Intralesional Cryosurgery Good for Deep Lesions : Procedure reduced scar hardness, elevation, and redness; no recurrences were reported at 18 months.
MDedge Dermatology
Data Validate Some Lipolysis, but Not Mesotherapy
MDedge Dermatology
Ultrasound Breaks Up Subcutaneous Fat; May Be Liposuction Alternative
MDedge Dermatology
Expert Shares Start-to-Finish Thread Lift Pearls : Procedure's success depends on identifying and correctly marking the area of facial 'descent.'
MDedge Dermatology
Real-World Comparative Data Place Radiesse Over Sculptra
MDedge Dermatology
A Review of Melasma, Part 2: Therapy
MDedge Dermatology
Efficacy and Tolerability of Kinetin 0.1% Cream for Improving the Signs of Photoaging in Facial and Neck Skin
MDedge Dermatology
Nonablative Fractional Laser Resurfacing for Atrophic and Acne Scarring
MDedge Dermatology
The FDA and Dermatology
MDedge Dermatology